GLP1R and type 2 diabetes mellitus: Although little is known about sustainability of the effects of GLP-1 receptor agonists after drug withdrawal, recent clinical studies found that the beneficial effect was lost after the end of treatment of exenatide [11] and liraglutide [37] in type 2 diabetic patients.